IP in the life sciences industries 2009

Articles

Welcome

It is a pleasure to welcome you to IP in the Life Sciences Industries 2009, a special supplement of Intellectual Asset Management magazine.
Sara-Jayne Adams

Managing IP in open innovation partnerships

Open innovation is growing in popularity as an increasing number of companies seek to collaborate on research and product development. However, for the process to work, it is vital that all the IP angles are understood and acted upon
John Cronin and Katherine Shore

Taking the heat out of the global patent system

Global patent warming is real, not imaginary. And while it may suit some, for many others it will cause increasing problems. At the world’s major patent offices, solutions are being sought. It could all mean that change is on the way
Ciaran McGinley

Exclusive marketing rights revisited in India

Interest in the repealed exclusive marketing rights provisions has been revived by a Supreme Court ruling which clarifies the effect of the repeal on the litigation of pending and decided applications
Nupur Maithani and Priyanka Vyas

Life sciences patent strategies in Europe

The European market can be a daunting one, due to the lack of a unified patent system. However, life sciences companies can employ a number of tactics in order to arrive at a successful IP strategy for patent protection
Inga-Lill Andersson, Karl Olsson and Maria Stenbäck

IP issues in outsourcing R&D

Life sciences companies are increasingly outsourcing R&D to keep pace with scientific and technological advancements and tougher regulatory demands. In selecting the optimal approach, they must take care to assess the opportunities and potential pitfalls
Daryl Fairbairn and Claudia Milbradt

Key IP issues for life sciences companies doing business in China

Life sciences companies seeking to crack the challenging yet lucrative Chinese market must arm themselves with the necessary knowledge to minimise risk and maximise gain
Cedric Lam and Isabella Liu

Protecting biotech inventions in Europe

The question of what constitutes patentable subject matter is particularly relevant to biotech inventions, not least due to the ethical issues they present. Answers can be found in the EPC 2000 and in EPO case law and practice
Regula Béatrice Rüedi and Julia Molitor

Pharmaceutical patents in Italy: hot topics

Timely issues preoccupying pharmaceutical patent owners in Italy include the duration of supplementary protection certificates, the extent of the Bolar exemption and the recovery of damages for infringement
Federica Santonocito and Agata Sobol

Key issues of pharmaceutical trademarks

Due to their importance to public health, pharmaceutical trademarks are affected not only by IP law, but also by regulatory law. Trademark owners must thus be prepared to tackle questions which are often rooted in the political, financial or technical context
Martin Viefhues

What life sciences investors should know about IP

The vast sums and long lead times required to bring life sciences projects to fruition demand a nuanced understanding of both the perils of mismanaging IP and the opportunities arising from successful IP management
Kfir Luzzatto

Gene patenting and stem-cell related inventions

Gene patent applicants are considering the implications of an apparent relaxation of the “same invention” requirement for entitlement to priority; while patentability is exercising those involved in stem-cell research
BW Swinkels and Caroline Pallard

Enforcing plant variety rights in Mexico

Enforcement of plant variety rights in Mexico can be challenging, due to the limited legal remedies available and the peculiarities of the domestic market. However, thanks to the efforts of the relevant authorities, strong protection is nonetheless available
Abraham Diaz

Patent term and double dipping

Pharmaceutical companies have dreamed up numerous strategies to forestall the loss of profits when a patent expires. But one simple way to maximise profits is to ensure a correct patent term calculation
Wendy A Choi and Charlie C Lyu

Close

Register for more free content

  • Read more IAM blogs and articles
  • Receive the editor's weekly review by email
Register now  
Issue 84